NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Neuren approaching key milestones in Q4 2019, page-52

  1. 80 Posts.
    lightbulb Created with Sketch. 10
    Totally agree with you. It seems people are over reacting here. That caused the confusion as to whether Dr T is capable of delivering the outcome "in time" , yet the timing is still under control from my takeaway from the content in this annoucement.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.